These clinical images and videos depict the case of a patient undergoing TAVR, during which attempts to deploy a 29 mm Evolut-Pro valve at a depth of 5 mm below the annulus resulted in migration to the aorta.
The AVENTUS Trial successfully met its primary endpoints, demonstrating both safety and efficacy in the treatment of acute intermediate-risk pulmonary embolism (PE) patients.
The Paradise ultrasound Renal Denervation (uRDN) System (Recor Medical, Inc.) uses circumferential ultrasound energy to thermally ablate and disrupt sympathetic nerves along the renal arteries.
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in…
Video Supplement to “Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium” (Clinical Image).
A 33-year-old man with Behçet’s disease presented with new retrosternal chest pain and was transferred for primary percutaneous coronary intervention due to inferior ST-segment elevation…
Engineered using an acrylic formula infused with bismuth (Bi), a non-toxic and stable element, ClearShield panels are transparent, eco-conscious, and manufactured entirely in the United…
The authors summarize studies on percutaneous coronary intervention complications, including coronary dissection, no reflow, perforation, and equipment loss/entrapment.
The authors summarize studies on percutaneous coronary intervention complications, including coronary dissection, no reflow, perforation, and equipment loss/entrapment.
The authors report a precise endomyocardial biopsy procedure in a patient with unexplained heart failure under guidance of an electroanatomical mapping system, which can avoid…
The SUCCESS PTA Study 12-month results were presented on April 23 at the Charing Cross Symposium in London. The SELUTION SFA Japan Trial 3-year results followed on April 25 at…
